Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

CAPRIE Steering Committee.

Lancet. 1996 Nov 16;348(9038):1329-39.

PMID:
8918275
[PubMed - indexed for MEDLINE]
2.

Aspirin for preventing the recurrence of venous thromboembolism.

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASA Investigators.

N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238. Erratum in: N Engl J Med. 2012 Oct 18;367(16):1573.

PMID:
22621626
[PubMed - indexed for MEDLINE]
Free Article
3.

Aspirin to prevent heart attack and stroke: what's the right dose?

Dalen JE.

Am J Med. 2006 Mar;119(3):198-202. Review.

PMID:
16490462
[PubMed - indexed for MEDLINE]
4.

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators.

Lancet. 2004 Jul 24-30;364(9431):331-7.

PMID:
15276392
[PubMed - indexed for MEDLINE]
5.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators.

N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2.

PMID:
22551105
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z.

Lancet. 2012 Apr 28;379(9826):1591-601. doi: 10.1016/S0140-6736(12)60209-8. Epub 2012 Mar 21.

PMID:
22440947
[PubMed - indexed for MEDLINE]
7.

The mechanism of action of aspirin.

Vane JR, Botting RM.

Thromb Res. 2003 Jun 15;110(5-6):255-8. Review.

PMID:
14592543
[PubMed - indexed for MEDLINE]
8.

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA.

N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.

PMID:
22931315
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A.

Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.

PMID:
19482214
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.

Stampfer MJ, Buring JE, Willett W, Rosner B, Eberlein K, Hennekens CH.

Stat Med. 1985 Apr-Jun;4(2):111-6.

PMID:
4023472
[PubMed - indexed for MEDLINE]
11.

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW.

Lancet. 2012 Apr 28;379(9826):1602-12. doi: 10.1016/S0140-6736(11)61720-0. Epub 2012 Mar 21. Review.

PMID:
22440946
[PubMed - indexed for MEDLINE]
12.

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S.

N Engl J Med. 2012 Oct 25;367(17):1596-606. doi: 10.1056/NEJMoa1207756.

PMID:
23094721
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Low-dose aspirin for preventing recurrent venous thromboembolism.

Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J; ASPIRE Investigators.

N Engl J Med. 2012 Nov 22;367(21):1979-87. doi: 10.1056/NEJMoa1210384. Epub 2012 Nov 4.

PMID:
23121403
[PubMed - indexed for MEDLINE]
Free Article
14.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT; CAPP2 Investigators.

Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.

PMID:
22036019
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

Jaturapatporn D, Isaac MG, McCleery J, Tabet N.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD006378. doi: 10.1002/14651858.CD006378.pub2. Review.

PMID:
22336816
[PubMed - indexed for MEDLINE]
17.

Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.

Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG.

Gastroenterology. 2012 Jun;142(7):1504-15.e3. doi: 10.1053/j.gastro.2012.02.050. Epub 2012 Mar 6.

PMID:
22406476
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome.

Zeitz HJ.

Clin Chest Med. 1988 Dec;9(4):567-76. Review.

PMID:
3069289
[PubMed - indexed for MEDLINE]
19.

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.

Diener HC, Eikelboom J, Connolly SJ, Joyner CD, Hart RG, Lip GY, O'Donnell M, Hohnloser SH, Hankey GJ, Shestakovska O, Yusuf S; AVERROES Steering Committee and Investigators.

Lancet Neurol. 2012 Mar;11(3):225-31. doi: 10.1016/S1474-4422(12)70017-0. Epub 2012 Feb 1.

PMID:
22305462
[PubMed - indexed for MEDLINE]
20.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW.

Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.

PMID:
21144578
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk